<--- Back to Details
First PageDocument Content
Antimicrobial prophylaxis / Surgery / Bacterial diseases / Gram-positive bacteria / Bacteremia / Sepsis / Vancomycin / Clostridium difficile / Norfloxacin / Medicine / Infectious diseases / Intensive care medicine
Date: 2015-03-10 01:06:13
Antimicrobial prophylaxis
Surgery
Bacterial diseases
Gram-positive bacteria
Bacteremia
Sepsis
Vancomycin
Clostridium difficile
Norfloxacin
Medicine
Infectious diseases
Intensive care medicine

Add to Reading List

Source URL: www.cec.health.nsw.gov.au

Download Document from Source Website

File Size: 436,66 KB

Share Document on Facebook

Similar Documents

Protecting Newborns by Expanding Locally Manufactured QualityAssured Medicines The use of chlorhexidine gel on newborns is effective in preventing life-threatening sepsis and umbilical cord infections.

DocID: 1vlUr - View Document

Hacettepe’de Dünya Sepsis Günü Etkinliği, Basında sıklıkla yer alan yoğun bakımdaki hasta ölümlerinin temel nedenlerinden biri olan sepsis, hem gelişmekte olan hem de gelişmiş ülkelerde sık görülen an

DocID: 1vgeY - View Document

IMPROVING PEDIATRIC SEPSIS OUTCOMES A multi-year collaborative for children’s hospitals to reduce sepsis mortality and morbidity across all levels of care. WHAT’S INSIDE Executive Summary.............................

DocID: 1vbKE - View Document

Frequently Asked Questions  What is IPSO? The IPSO (Improving Pediatric Sepsis Outcomes) is a quality improvement collaborative of children’s hospitals addressing diagnosis and treatment across the hospital. IPSO ai

DocID: 1vajS - View Document

2018 年 5 月 30 放送 「Sepsis-3 における敗血症管理」 名古屋大学大学院 救急・集中治療医学教授

DocID: 1v1xA - View Document